Chiome Bioscience Inc.: Clinical Trials

2 trials sponsored by Chiome Bioscience Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2

Follow Chiome Bioscience Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.
CBA-1535, CBA-1535+Pembrolizumab - Solid Tumors, Refractory Cancer
Phase 1RecruitingChiome Bioscience Inc.702022-06-272025-06-12
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
CBA-1205 Part 1, CBA-1205 Part 2, CBA-1205 Part 3 - Solid Tumors, Hepatocellular Carcinoma (HCC)
Phase 1RecruitingChiome Bioscience Inc.662020-06-012026-06-17

Conditions studied

Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Melanoma (1)

Countries

Japan (2)

Results publications

PMID 39832211